Thiadiazole derivatives as New Class of β-glucuronidase inhibitors

Bioorg Med Chem. 2016 Apr 15;24(8):1909-18. doi: 10.1016/j.bmc.2016.03.020. Epub 2016 Mar 10.

Abstract

Thiadiazole derivatives 1-24 were synthesized via a single step reaction and screened for in vitro β-glucuronidase inhibitory activity. All the synthetic compounds displayed good inhibitory activity in the range of IC50=2.16 ± 0.01-58.06 ± 1.60 μM as compare to standard d-saccharic acid 1,4-lactone (IC50=48.4 ± 1.25 μM). Molecular docking study was conducted in order to establish the structure-activity relationship (SAR) which demonstrated that thiadiazole as well as both aryl moieties (aryl and N-aryl) involved to exhibit the inhibitory potential. All the synthetic compounds were characterized by spectroscopic techniques (1)H, (13)C NMR, and EIMS.

Keywords: In vitro; Molecular docking; Structure–activity relationship; Synthesis; Thiadiazole; β-Glucuronidase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cattle
  • Dose-Response Relationship, Drug
  • Glucuronidase / antagonists & inhibitors*
  • Glucuronidase / metabolism
  • Glycoproteins / chemical synthesis
  • Glycoproteins / chemistry
  • Glycoproteins / pharmacology*
  • Liver / enzymology
  • Molecular Docking Simulation
  • Molecular Structure
  • Structure-Activity Relationship
  • Thiadiazoles / chemical synthesis
  • Thiadiazoles / chemistry
  • Thiadiazoles / pharmacology*

Substances

  • Glycoproteins
  • Thiadiazoles
  • beta-glucuronidase inhibitor
  • Glucuronidase